Response durability up to 6 years in #mCRPC ; in over 150 patients, 3 individuals remained in long-term remission. “duration of response” not equal to PFS. #DOR.#mCRPC.#Precisionmedicine .

A keynote speaker at the 5th International Emirates Annual Conference& Arab Society of Nuclear medicine & Molecular Imaging in Dubai, about the latest advances in #theranostics in #meningioma — an exciting and evolving field with real potential to transform patient outcomes.

RT @oncodaily: Therapeutic Potential of 68Ga/177Lu-DOTATATE in Metastatic Medullary Thyroid Carcinoma by Majid Assadi et al. @AssadiMajidMD….

68Ga-DOTA-LM3 PET/CT: A Somatostatin Receptor Antagonist in a Patient with Progressive Meningioma. Exploring new imaging approaches for better tumor characterization and management. #SSTR_Antagonist #NeuroOncology #PETCT #Meningioma

Continuing our exploration of FDG PET and FAPI PET in diagnosing #ILD, a complex fibrotic-inflammatory condition. A biopsy-proven ILD case—pulmonary alveolar microlithiasis—showing positive FAPI PET but negative FDG PET, offering intriguing insights into disease characterization.

Successful treatment of a patient with multiple primary metachronous malignancies, including #NET in 2009, (meningioma in 2010), uterine cancer in 2017, and breast cancer in 2019. The patient received #PRRT at our center in 2016. It's essential to prioritize #PrecisionMedicine.

Dual #SSTR and #FAPI PET imaging in progressive relapsed/refractory #meningiomas showing significantly greater intensity on SSTR compared to FAPI PET. #Neurotheranostics .#CIC_SNMMI

We are excited to share that Esmail Jafari, our #MolecularImaging PhD candidate, successfully defended his PhD thesis on AI, #PSMAPET and #prostatecancer today. During his course, he published about 30 papers.

our institute has been officially recognized as a "Comprehensive National Center of Excellence" in Nuclear Medicine and Molecular Imaging by the Ministry of Health and Medical Education. It features a preclinical imaging lab along with specialized imaging and theranostic units.

Our paper on distinguishing fibroinflammatory process using #FAP imaging in #ILD just came out.

Good response to the combined 177Lu/225Ac-DOTATATE treatment in a patient with recurrent and progressive meningioma –surgery and radiation refractory. Dizziness, weakness, convulsions, speech, and personality changes totally gone following treatment. #Meningioma. #Theranostics

Our study on the development and evaluation of a fully automated tool for detecting and segmenting mPCa lesions in whole-body [68Ga]Ga-#PSMA #PET came out. Hope.to develop comprehensive structured report template for 68Ga-PSMA PET/CT #prostatecancer .

Today, targeted #alpha therapy using #225Ac_ PSMA brought renewed hope for 6 late-stage #prostate cancer patients. Exciting clinical progress continues!.Special thanks to professor .Mike Sathekge for his wise counsel and support throughout.

I'm excited to invite you to our upcoming presentation on 68Ga-#FAPI PET/CT and MIBI SPECT/CT in Interstitial Lung Disease In #EANM23. 🫁 As part of our groundbreaking research project, we believe these imaging techniques could be a total game-changer in the management of #ILDs.

Small Animal Imaging Workshop . overview on state-of-the-art small animal imaging tools including PET, SPECT, CT and optical imaging. #Preclinical .

Our project on #SSTR imaging for detecting biological activity of atherosclerotic #plaques just published. incentive for exploration of #theranostics to identify and treat high-risk atherosclerotic plaques in this systematic disease(#CAD).

After four years, our book just published. 32 chapters ,written by leading scientists/ experts ,richly illustrated (> 600 images). We dedicated to the memory of pro. Sanjive Sam Gambhir. A gentle giant of science has left this world too early.

Our project on “Development and characterization of #PDL1 #radiotheranostics in lung cancer” just accepted.

Predictive and prognostic potential of pretreatment #68GaPSMAPET tumor #heterogeneityindex in patients with metastatic castration-resistant #prostatecancer treated with #177LuPSMA @ASCO #GU23